PHARMACEUTICAL COMPOSITION AND ITS USE Russian patent published in 2022 - IPC A61K31/7048 A61K31/121 A61K31/343 A61K31/58 A61P9/10 

Abstract RU 2786387 C2

FIELD: pharmaceutical industry.

SUBSTANCE: group of inventions relates to the pharmaceutical industry, namely to a composition for the treatment or prevention of myocardial damage or heart failure. The pharmaceutical composition for the treatment or prevention of myocardial damage or heart failure contains following components: phenolic acids of 2-20 parts by weight; flavonoids of 0.5-5 parts by weight; tanshinones of 0.005-0.5 part by weight; saponins of 5-20 parts by weight; essential oils of 10-18 parts by weight. In this case, phenolic acids include Danshen, protocatechuic aldehyde, salvianolic acid T, salvianolic acid U, salvianolic acid D, salvianolic acid G, rosemary acid, lithospermic acid, salvianolic acid B, salvianolic acid A, isosalvianolic acid C; flavonoids include calicosin-7-glucoside, ononin, calicosin, formononetin; tanshinones include dihydrotanshinone I, cryptotanshinone, tanshinone I, tanshinone IIA; saponins include notoginsenoside R1, ginsenoside Rg1, ginsenoside Rb1, astragaloside, ginsenoside Rd; and essential oils include trans-nerolidol, nerolidol oxide. The use of the above-described pharmaceutical composition for the production of a drug for improvement of a condition in myocardial damage or a drug for the treatment or prevention of heart failure is also described. A pharmaceutical drug for the treatment or prevention of myocardial damage or heart failure contains the above-described pharmaceutical composition, where the pharmaceutical composition is 0.1~99.9 wt.% of the pharmaceutical drug, and the rest is a pharmaceutically acceptable carrier (carriers). A method for the treatment or prevention of myocardial damage or heart failure includes administration of effective amount of the above-described pharmaceutical composition or pharmaceutical drug to a subject, which has myocardial damage and/or heart failure or the risk of their presence.

EFFECT: above-described composition and drug have synergetic activity relatively to the treatment or prevention of myocardial damage or heart failure.

26 cl, 6 dwg, 12 tbl, 3 ex

Similar patents RU2786387C2

Title Year Author Number
COMPOSITION FOR HEART DISEASES TREATMENT, METHOD OF SPECIFIED COMPOSITION PRODUCTION AND APPLICATION OF SPECIFIED COMPOSITION 2003
  • Jan Ksizhun
  • Vu Najfen
  • Guo Zhiksin
  • E Zhenglian
  • L'Ju Jan
RU2328300C2
NEW SALVIANOLIC ACID COMPOUND T, PREPARATION METHOD THEREFOR AND USE THEREOF 2014
  • Zhou, Shuiping
  • Li, Wei
  • Jin, Yuanpeng
  • Li, Xinxin
  • Ma, Xiaohui
  • Zhou, Wei
  • Han, Min
  • Li, Shuming
RU2668955C2
CHINESE DRUG COMPOSITION FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES OR DEMENTIA AND METHOD FOR PRODUCTION THEREOF 2015
  • Lyu Tszyansyun
  • Chzhan Vivian
  • Li Chzhigan
  • Chzhan Shifliski
  • Guan Syuvej
  • Lu Iris
  • Gao Vejbo
  • Syuj Li
  • Sun Ventin
RU2674264C1
SALVIANOLIC ACID L COMPOUND, METHOD OF THREOF PREPARATION AND APPLICATION 2010
  • Zhou Shuiping
  • Li Wei
  • Jin Yuanpeng
  • Ma Xiaohui
  • Han Jianping
  • Cui Hongfang
  • Luo Xuejun
  • Chen Xiaopeng
RU2529491C2
RADIX SALVIAE MILTIORRHIZAE (DAN SHEN) OR PREPARATIONS THEREOF APPLICATION FOR PREPARATION OF DRUGS FOR TREATMENT OF DISEASES RELATED TO LIVER FIBROSIS 2013
  • Zhu Yonghong
  • Hu Jinfang
  • Ma Jie
  • Shen Xiuping
RU2623147C2
PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY 2007
  • Chzhan Tszoguan
RU2444369C2
PHARMACEUTICAL COMPOSITIONS WITH MULTIPURPOSE RECEPTOR REACTION MECHANISM FOR TREATING DEPRESSION 2007
  • Chzhan Tszoguan
RU2452505C2
PHARMACEUTICAL COMPOSITIONS FOR DEPRESSION AND ANXIETY DISORDER (VERSIONS) 2007
  • Chzhan Tszoguan
RU2449804C2
SYNERGISTIC COMPOSITION OF VEGETABLE ORIGIN (VARIANTS), METHOD FOR TREATMENT OF DISEASES WITH ITS USING 2005
  • Olalde Rankhel' Khose Ankhel'
RU2319494C2
MEDICINAL PREPARATION FOR TREATMENT OF DISEASES OF CARDIOCEREBRAL BLOOD VESSELS AND WAY OF ITS MANUFACTURING 2005
  • Cheng Iju
  • Zhang Khajdzhiang
  • E. Zhengliang
RU2359692C2

RU 2 786 387 C2

Authors

Chzhou, Shujpin

Sun, Khe

Chzhan, Itsyan

Ma, Syaokhuej

Shi, Tszyaven

Khe, I

Li, Sinsin

Van, Tszin

Li, Syaotsin

Fan, Litszyun

Chzhan, Tszintszin

Dates

2022-12-20Published

2019-04-04Filed